Cargando…
Efficacy of Add-on Montelukast in Nonasthmatic Eosinophilic Bronchitis: The Additive Effect on Airway Inflammation, Cough and Life Quality
BACKGROUND: The efficacy of montelukast (MONT), a cysteinyl leukotriene receptor antagonist, in nonasthmatic eosinophilic bronchitis (NAEB), especially its influence on cough associated life quality is still indefinite. We evaluated the efficacy of MONT combined with budesonide (BUD) as compared to...
Autores principales: | Bao, Wuping, Liu, Ping, Qiu, Zhongmin, Yu, Li, Hang, Jingqing, Gao, Xiaohua, Zhou, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837817/ https://www.ncbi.nlm.nih.gov/pubmed/25563311 http://dx.doi.org/10.4103/0366-6999.147805 |
Ejemplares similares
-
Clinical Outcome of Eosinophilic Airway Inflammation in Chronic Airway Diseases Including Nonasthmatic Eosinophilic Bronchitis
por: Cho, Jaeyoung, et al.
Publicado: (2018) -
Role of PGE(2) in Asthma and Nonasthmatic Eosinophilic Bronchitis
por: Sastre, Beatriz, et al.
Publicado: (2012) -
Eotaxin and IL-4 levels are increased in induced sputum and correlate with sputum eosinophils in patients with nonasthmatic eosinophilic bronchitis
por: Zhang, Rui, et al.
Publicado: (2017) -
Duration of treatment with inhaled corticosteroids in nonasthmatic
eosinophilic bronchitis: a randomized open label trial
por: Zhan, Wenzhi, et al.
Publicado: (2019) -
Nonasthmatic eosinophilic bronchitis in an ulcerative colitis patient – a putative adverse reaction to mesalazine: A case report and review of literature
por: Cernomaz, Andrei Tudor, et al.
Publicado: (2020)